Prasugrel Re-load Strategies

Summary

Prasugrel Re-load Strategies is a clinical trial^[1].

Key Facts

• Prasugrel Re-load Strategies is in the country of United States^[2].
• Prasugrel Re-load Strategies's instance of is recorded as clinical trial^[3].
• Prasugrel Re-load Strategies's start time is recorded as +2010-08-31T00:00:00Z^[4].
• Prasugrel Re-load Strategies's end time is recorded as +2011-05-31T00:00:00Z^[5].
• Prasugrel Re-load Strategies's sponsor is recorded as University of Florida^[6].
• Prasugrel Re-load Strategies's main subject is recorded as coronary artery disease^[7].
• Prasugrel Re-load Strategies's number of participants is recorded as {'unit': '1', 'amount': '+65'}^[8].
• Prasugrel Re-load Strategies's title is recorded as Impact of Prasugrel Re-load on Platelet Aggregation in Patients on Chronic Prasugrel Therapy^[9].
• Prasugrel Re-load Strategies's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Prasugrel Re-load Strategies's ClinicalTrials.gov ID is recorded as NCT01201772^[11].
• Prasugrel Re-load Strategies's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+74'}^[12].
• Prasugrel Re-load Strategies's research intervention is recorded as prasugrel hydrochloride^[13].
• Prasugrel Re-load Strategies's clinical trial phase is recorded as phase IV clinical trial^[14].
• Prasugrel Re-load Strategies's research site is recorded as University of Florida^[15].
• Prasugrel Re-load Strategies's study type is recorded as interventional study^[16].